News
BAYZF
51.25
NaN%
--
Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus
Seeking Alpha · 11h ago
Bayer to invest $2.2B in new manufacturing site in New Albany, Ohio
TipRanks · 2d ago
Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States
Barchart · 2d ago
Bayer to relaunch Alka-Seltzer Plus as Alka-Seltzer Cold in 2026
TipRanks · 3d ago
J.P. Morgan Remains a Buy on Bayer (0P6S)
TipRanks · 3d ago
Bayer announces launch of MiraSOFT at CVS Pharmacy
TipRanks · 5d ago
Deutsche Bank Reaffirms Their Buy Rating on Bayer (0P6S)
TipRanks · 5d ago
Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits
Seeking Alpha · 6d ago
Bayer announces FDA accepts Lynkuet sNDA for Priority Review
TipRanks · 6d ago
Weekly Report: what happened at BAYZF last week (0921-0925)?
Weekly Report · 6d ago
Midday Fly By: McDonald’s lays out new strategy, General Mills reports Q1 beat
TipRanks · 09/23 16:00
Bayer to sell cancer drug Stigvarga for up to $431M, WSJ reports
TipRanks · 09/23 10:05
Weekly Report: what happened at BAYZF last week (0914-0918)?
Weekly Report · 09/21 09:00
Robigo announces Series A funding led by Leaps by Bayer
TipRanks · 09/17 13:15
Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes
TipRanks · 09/17 09:30
Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs
Barchart · 09/17 08:05
Weekly Report: what happened at BAYZF last week (0907-0911)?
Weekly Report · 09/14 09:00
Bayer granted accelerated approval for Hyrnuo by FDA
TipRanks · 09/10 09:30
Deutsche Bank Reaffirms Their Buy Rating on Bayer (0P6S)
TipRanks · 09/10 08:05
FDA grants accelerated approval to added indication for Bayer’s sevabertinib
TipRanks · 09/09 15:40
More
Webull provides a variety of real-time BAYZF stock news. You can receive the latest news about Bayer A G through multiple platforms. This information may help you make smarter investment decisions.
About BAYZF
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.